| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
4 companies
Exter Neil serves as a Director at RVMD and has filed Form 4s across 4 companies. Across recent SEC filings that breaks down to 0 buys and 7 sells. Those positions are worth an estimated $5.9M at current prices.
Historically, Exter Neil's trades have earned a middling insider score of 66/100 across 5 rated trades. Over a 12-month horizon, 80.0% of those trades were profitable, with an average 12-month return of +28.9%.
The biggest single holding is RVMD (~$5.9M) as Director.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 8, 2022 | RVMD Revolution Medicines, Inc. | Director | Sell | 0 | $0.00 | - | New | +2.0% | +26.6% | |
| Jun 4, 2021 | RVMD Revolution Medicines, Inc. | Director | Sell | 0 | $0.00 | - | New | -2.2% | -37.3% | |
| May 26, 2021 | RVMD Revolution Medicines, Inc. | Director | Sell | 0 | $0.00 | - | New | -16.2% | -48.7% | |
| Mar 27, 2017 | CTMX Cytomx Therapeutics, Inc. | Director | Sell | 0 | $0.00 | - | New | - | - |